Overall survival in patients treated since 2008 is nearly 20% higher than in earlier patients
On-demand stem cell mobilizer is an effective salvage strategy
Why enhancing clinical care is critical for patient outcomes
Plasma cell-targeted therapy helps patient with rare condition
Advertisement
Cleveland Clinic is a non-profit academic medical center. Advertising on our site helps support our mission. We do not endorse non-Cleveland Clinic products or services. Policy
Can PACT pinpoint vulnerable patients?
Some mutations associated with higher risk of relapse
Advertisement
Advertisement